Skip to main content

RheeGen's Topical Stem Cell Therapy Pioneers Future of Regenerative Medicine

TAMPA, FL / ACCESS Newswire / April 8, 2025 / Dr. Thomas Rhee, a renowned sports chiropractor and medical innovator, is pioneering a new frontier in regenerative medicine with the development of RheeGen's topical transdermal stem cell therapy. This non-invasive, cost-effective alternative to traditional injection-based treatments is at the center of his new book, The Future of Regenerative Medicine: Unlocking the Potential of Topical Stem Cell Therapy. As the founder of RheeGen and a practitioner with experience spanning from UCLA to the Tampa Bay Buccaneers, Dr. Rhee brings deep clinical insight to this groundbreaking approach.

The newly released book explores how this forward-thinking approach is poised to transform recovery, rehabilitation, and performance enhancement for both athletes and individuals with chronic conditions.

A Breakthrough in Regenerative Medicine

RheeGen's new method enables stem cells to be absorbed through the skin, making treatments safer and more affordable than conventional injection-based therapies.

In addition to creating RheeGen, Dr. Rhee founded Physical Chiropractic of Tampa Bay, a leading therapy clinic in the region.

Dr. Rhee explains why topical stem cell therapy represents the next major advance in regenerative medicine: "Our research shows that this approach not only works, but it also offers a safer and more accessible way to treat injuries and promote healing."

Eliminating the Need for Injections

Traditional stem cell therapy typically involves invasive injections, which can be painful, carry a risk of infection, and are often costly. RheeGen's topical treatment eliminates the need for such procedures.

Instead, stem cells are delivered transdermally-through the skin-offering a more comfortable and convenient treatment experience. This method delivers the same regenerative benefits as injections, without the need for needles or invasive surgery.

Using advanced transdermal technology, RheeGen's therapy presents a more practical and patient-friendly solution for injury recovery. It is particularly beneficial for athletes seeking faster healing while avoiding the discomfort and downtime associated with injections.

Transforming Recovery and Rehabilitation

RheeGen's topical stem cell therapy is set to redefine approaches to recovery and rehabilitation. For athletes, it means shorter recovery times. For individuals with chronic conditions, it offers a new method to heal muscles, tendons, ligaments, bones, and cartilage.

Dr. Rhee's research centers on how this innovative therapy stimulates the body's natural healing mechanisms. By reducing inflammation and encouraging tissue regeneration, this breakthrough delivers faster and more effective recovery outcomes than traditional methods.

Industry Leadership and Innovation

As a pioneer in the field, RheeGen is not only developing new therapies but also educating healthcare professionals about the benefits of topical stem cell applications. By increasing accessibility, the company is helping reshape how injuries are treated and chronic conditions are managed.

Dr. Rhee's book, The Future of Regenerative Medicine, explores the science behind topical stem cell therapy and its transformative potential. It includes real-world case studies, such as the story of Jeff, whose remarkable recovery illustrates the therapy's efficacy.

A New Era for Medical Advancements

RheeGen's discovery marks the beginning of a new era in regenerative medicine. The book highlights how this innovation is making stem cell therapy safer, more effective, and available to a wider range of patients.

By bridging the gap between cutting-edge scientific research and real-world application, RheeGen is helping shape the future of healthcare and establishing itself as a true trailblazer in medical innovation.

Contact:

At Large PR
Melinda Copeland
publicrelations@atlargeproutreach.com
Tampa, Florida

SOURCE: At Large PR



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.